These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9084808)

  • 41. Semen virome of men with HIV on or off antiretroviral treatment.
    Li Y; Altan E; Pilcher C; Hartogensis W; Hecht FM; Deng X; Delwart E
    AIDS; 2020 May; 34(6):827-832. PubMed ID: 32271249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent observations on HIV type-1 infection in the genital tract of men and women.
    Coombs RW; Reichelderfer PS; Landay AL
    AIDS; 2003 Mar; 17(4):455-80. PubMed ID: 12598766
    [No Abstract]   [Full Text] [Related]  

  • 43. Genetic characterization of HIV-1 from semen and blood from clade C-infected subjects from India and effect of therapy in these body compartments.
    Shen C; Ding M; Craigo JK; Tarwater P; Chatterjee R; Roy P; Guha SK; Saha B; Modak D; Neogi D; Chen Y; Gupta P
    Virology; 2010 Jun; 401(2):190-6. PubMed ID: 20231027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dynamics of seminal plasma HIV-1 decline after antiretroviral treatment.
    Taylor S; Ferguson NM; Cane PA; Anderson RM; Pillay D
    AIDS; 2001 Feb; 15(3):424-6. PubMed ID: 11273229
    [No Abstract]   [Full Text] [Related]  

  • 45. Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract.
    Torres-Cornejo A; BenMarzouk-Hidalgo OJ; Viciana P; Sánchez B; López-Ruz MA; López-Cortés LF; Gutiérrez-Valencia A
    Clin Microbiol Infect; 2016 Jan; 22(1):98.e7-98.e10. PubMed ID: 26454060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human immunodeficiency virus type 1 dynamics in different lymphoid tissue compartments.
    Lafeuillade A; Poggi C; Tamalet C; Profizi N
    J Infect Dis; 1997 Sep; 176(3):804-6. PubMed ID: 9291339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012).
    Leruez-Ville M; Dulioust E; Costabliola D; Salmon D; Tachet A; Finkielsztejn L; De Almeida M; Silbermann B; Sicard D; Jouannet P; Rouzioux C
    AIDS; 2002 Feb; 16(3):486-8. PubMed ID: 11834963
    [No Abstract]   [Full Text] [Related]  

  • 48. Risk factors for HIV-1 shedding in semen.
    Speck CE; Coombs RW; Koutsky LA; Zeh J; Ross SO; Hooton TM; Collier AC; Corey L; Cent A; Dragavon J; Lee W; Johnson EJ; Sampoleo RR; Krieger JN
    Am J Epidemiol; 1999 Sep; 150(6):622-31. PubMed ID: 10490002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early treatment of HIV infection.
    Schwartz DH
    N Engl J Med; 1995 Dec; 333(26):1782; author reply 1783. PubMed ID: 7491154
    [No Abstract]   [Full Text] [Related]  

  • 50. Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy.
    Hamed KA; Winters MA; Holodniy M; Katzenstein DA; Merigan TC
    J Infect Dis; 1993 Apr; 167(4):798-802. PubMed ID: 8450243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV viral shedding in semen: lack of correlation with systemic virus-specific CD8 responses.
    Sheth PM; Shahabi K; Rebbapragada A; Kovacs C; Dimayuga R; Chackalakkal S; MacDonald K; Mazzulli T; Kaul R
    AIDS; 2004 Nov; 18(16):2202-5. PubMed ID: 15577656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathophysiology of HIV-1 in semen: current evidence for compartmentalisation and penetration by antiretroviral drugs.
    Chan DJ
    Curr HIV Res; 2005 Jul; 3(3):207-22. PubMed ID: 16022654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV-1 shedding in genital tract of infected women.
    Burkhart CN
    Lancet; 2002 Apr; 359(9316):1526. PubMed ID: 11988284
    [No Abstract]   [Full Text] [Related]  

  • 54. Compartmentalization of HIV-1 according to antiretroviral therapy: viral loads are correlated in blood and semen but poorly in blood and saliva.
    Bourlet T; Cazorla C; Berthelot P; Grattard F; Cognasse F; Fresard A; Defontaine C; Lucht FR; Genin C; Pozzetto B
    AIDS; 2001 Jan; 15(2):284-5. PubMed ID: 11216944
    [No Abstract]   [Full Text] [Related]  

  • 55. HIV-1 shedding in genital tract of infected women.
    Fiore JR; Suligoi B; Monno L; Angarano G; Pastore G
    Lancet; 2002 Apr; 359(9316):1525-6. PubMed ID: 11988283
    [No Abstract]   [Full Text] [Related]  

  • 56. HIV-1 shedding in genital tract of infected women.
    Shields JW
    Lancet; 2002 Apr; 359(9316):1526. PubMed ID: 11988285
    [No Abstract]   [Full Text] [Related]  

  • 57. Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding.
    Fiore JR; Zoboli F; Di Stefano M; Faleo G; Fasano M; Santantonio TA
    AIDS; 2016 Apr; 30(7):1144-6. PubMed ID: 27028146
    [No Abstract]   [Full Text] [Related]  

  • 58. Mixture models for quantitative HIV RNA data.
    Moulton LH; Curriero FC; Barroso PF
    Stat Methods Med Res; 2002 Aug; 11(4):317-25. PubMed ID: 12197299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amyloid-binding small molecule reduces HIV infection.
    Future Med Chem; 2010 Nov; 2(11):1623. PubMed ID: 21428833
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of HIV-1 in semen following primary HIV-1 infection.
    Tindall B; Evans L; Cunningham P; McQueen P; Hurren L; Vasak E; Mooney J; Cooper DA
    AIDS; 1992 Sep; 6(9):949-52. PubMed ID: 1388906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.